CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
54.92
+0.94 (1.74%)
At close: Jun 26, 2026, 4:00 PM EDT
54.86
-0.06 (-0.11%)
After-hours: Jun 26, 2026, 7:59 PM EDT
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$10,440
Profits / Employee
-$1,446,651
Market Cap
5.30B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 393 | -14 | -3.44% |
| Dec 31, 2023 | 407 | -51 | -11.14% |
| Dec 31, 2022 | 458 | -15 | -3.17% |
| Dec 31, 2021 | 473 | 63 | 15.37% |
| Dec 31, 2020 | 410 | 106 | 34.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| Xenon Pharmaceuticals | 370 |
| Celcuity | 155 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
CRSP News
- 4 days ago - 3 Companies Redefining Healthcare Innovation - ETF Trends
- 11 days ago - The Healthcare M&A Wave - Forbes
- 17 days ago - Crispr Therapeutics assumed at Equal Weight from Underweight at Morgan Stanley - TheFly
- 19 days ago - CRISPR Therapeutics AG Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - CRISPR Therapeutics AG Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 25 days ago - CRISPR Therapeutics AG Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Crispr Therapeutics price target raised to $56 from $50 at Bernstein - TheFly